The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome
Open accessAbstract
BACKGROUND: Aortic-root dissection is the leading cause of death in Marfan's syndrome. Studies suggest that with regard to slowing aortic-root enlargement, losartan may be more effective than beta-blockers, the current standard therapy in most centers. METHODS: We conducted a randomized trial comparing losartan with atenolol in children and young adults with Marfan's syndrome. The primary outcome was the rate of aortic-root enlargement, expressed as the change in the maximum aortic-root-diameter z score indexed to body-surface area (hereafter, aortic-root z score) over a 3-year period. Secondary outcomes included the rate of change in the absolute diameter of the aortic root; the rate of change in aortic regurgitation; the time to aortic dissection, aortic-root surgery, or death; somatic growth; and the incidence of adverse events. RESULTS: From January 2007 through February 2011, a total of 21 clinical centers enrolled 608 participants, 6 months to 25 years of age (mean [±SD] age, 11.5±6.5 years in the atenolol group and 11.0±6.2 years in the losartan group), who had an aortic-root z score greater than 3.0. The baseline-adjusted rate of change in the mean (±SE) aortic-root z score did not differ significantly between the atenolol group and the losartan group (-0.139±0.013 and -0.107±0.013 standard-deviation units per year, respectively; P=0.08). Both slopes were significantly less than zero, indicating a decrease in the aortic-root diameter relative to body-surface area with either treatment. The 3-year rates of aortic-root surgery, aortic dissection, death, and a composite of these events did not differ significantly between the two treatment groups. CONCLUSIONS: Among children and young adults with Marfan's syndrome who were randomly assigned to losartan or atenolol, we found no significant difference in the rate of aortic-root dilatation between the two treatment groups over a 3-year period. (Funded by the National Heart, Lung, and Blood Institute and others; ClinicalTrials.gov number, NCT00429364.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
Dietz, H. C., Cutting, C. R., Pyeritz, R. E., Maslen, C. L., Sakai, L. Y., Corson, G. M., Puffenberger, E. G., Hamosh, A., Nanthakumar, E. J., Curristin, S. M., et al. (1991) · Nature · doi:10.1038/352337a0 · Cited by 2,070
Self-citationLoeys, B. L., Chen, J., Neptune, E. R., Judge, D. P., Podowski, M., Holm, T., Meyers, J., Leitch, C. C., Katsanis, N., Sharifi, N., et al. (2005) · Nature Genetics · doi:10.1038/ng1511 · Cited by 1,795
Self-citationLosartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
Self-citationRevised diagnostic criteria for the Marfan syndrome
De Paepe, A., Devereux, R. B., Dietz, H. C., Hennekam, R. C. M., & Pyeritz, R. E. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960424)62:4<417::aid-ajmg15>3.0.co;2-r · Cited by 1,572
Self-citationJudge, D. P., & Dietz, H. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67789-6 · Cited by 1,210
Self-citationShores, J., Berger, K. R., Murphy, E. A., & Pyeritz, R. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301902 · Cited by 1,071
Self-citationAngiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome
Brooke, B. S., Habashi, J. P., Judge, D. P., Patel, N., Loeys, B., & Dietz, H. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706585 · Cited by 843
Self-citationThe randomization and stratification of patients to clinical trials
Zelen, M. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90015-0 · Cited by 613
Lessons on the pathogenesis of aneurysm from heritable conditions
Lindsay, M. E., & Dietz, H. C. (2011) · Nature · doi:10.1038/nature10145 · Cited by 473
Self-citationTreatment of Aortic Disease in Patients With Marfan Syndrome
Milewicz, D. M., Dietz, H. C., & Miller, D. C. (2005) · Circulation · doi:10.1161/01.cir.0000155243.70456.f4 · Cited by 411
Self-citationGroenink, M., den Hartog, A. W., Franken, R., Radonic, T., de Waard, V., Timmermans, J., Scholte, A. J., van den Berg, M. P., Spijkerboer, A. M., Marquering, H. A., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht334 · Cited by 396
Lacro, R. V., Dietz, H. C., Wruck, L. M., Bradley, T. J., Colan, S. D., Devereux, R. B., Klein, G. L., Li, J. S., Minich, L. L., Paridon, S. M., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.024 · Cited by 231
Self-citationAngiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression.
Everett, A. D., Tufro-McReddie, A., Fisher, A., & Gomez, R. A. (1994) · Hypertension · doi:10.1161/01.hyp.23.5.587 · Cited by 194
Chiu, H.-H., Wu, M.-H., Wang, J.-K., Lu, C.-W., Chiu, S.-N., Chen, C.-A., Lin, M.-T., & Hu, F.-C. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.11.005 · Cited by 165
Naito, T., Masaki, T., Nikolic‐Paterson, D. J., Tanji, C., Yorioka, N., & Kohno, N. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00139.2003 · Cited by 158
TGF-β in the pathogenesis and prevention of disease: a matter of aneurysmic proportions
Dietz, H. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42014 · Cited by 118
Self-citationGrowth and maturation in Marfan syndrome
Erkula, G., Jones, K. B., Sponseller, P. D., Dietz, H. C., & Pyeritz, R. E. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10312 · Cited by 94
Self-citationDétaint, D., Aegerter, P., Tubach, F., Hoffman, I., Plauchu, H., Dulac, Y., Faivre, L. O., Delrue, M., Collignon, P., Odent, S., et al. (2010) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2010.04.008 · Cited by 79
Pees, C., Laccone, F. A., Hagl, M., DeBrauwer, V., Moser, E., & Michel‐Behnke, I. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.06.019 · Cited by 77
Gambarin, F. I., Favalli, V., Serio, A., Regazzi, M. B., Pasotti, M., Klersy, C., Dore, R., Mannarino, S., Viganò, M., Odero, A., et al. (2009) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283232a45 · Cited by 77
Möberg, K., Nobele, S. D., Devos, D., Goetghebeur, E. J. T., Segers, P., Trachet, B., Vervaet, C., Renard, M., Coucke, P. J., Loeys, B., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.12.070 · Cited by 63
Self-citationLacro, R. V., Guey, L. T., Dietz, H. C., Pearson, G. D., Yetman, A. T., Gelb, B. D., Loeys, B., Benson, D. W., Bradley, T. J., Backer, J. F. A. D., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.02.019 · Cited by 62
Self-citationFukuda, N., Hu, W., Kubo, A., Kishioka, H., Satoh, C., Soma, M., Izumi, Y., & Kanmatsuse, K. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00152-1 · Cited by 60
Tierney, E. S. S., Levine, J. C., Chen, S., et al. (2013) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2013.02.018 · Cited by 56
Self-citationMullen, M. J., Flather, M. D., Jin, X. Y., Newman, W. G., Erdem, G., Gaze, D. C., Valencia, O., BANYA, W. A. S., Foley, C. E., & Child, A. H. (2013) · Trials · doi:10.1186/1745-6215-14-408 · Cited by 28
Cited by
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Isselbacher, E. M., Preventza, O., Hamilton Black, J., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001106 · Cited by 2,082
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Editor's Choice – Management of Descending Thoracic Aorta Diseases
Riambau, V., Böckler, D., Brunkwall, J., Cao, P., Chiesa, R., Coppi, G., Czerny, M., Fraedrich, G., Haulon, S., Jacobs, M. J., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2016.06.005 · Cited by 1,246
Metadata
- Authors
- Lacro, R. V., Dietz, H. C., Sleeper, L. A., Yetman, A. T., Bradley, T. J., Colan, S. D., Pearson, G. D., Selamet Tierney, E. S., Levine, J. C., Atz, A. M., Benson, D. W., Braverman, A. C., Chen, S., De Backer, J., Gelb, B. D., Grossfeld, P. D., Klein, G. L., Lai, W. W., Liou, A., Loeys, B. L., Markham, L. W., Olson, A. K., Paridon, S. M., Pemberton, V. L., Pierpont, M. E., Pyeritz, R. E., Radojewski, E., Roman, M. J., Sharkey, A. M., Stylianou, M. P., Wechsler, S. B., Young, L. T., & Mahony, L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-11-27
- Volume
- 371
- Issue
- 22
- Pages
- 2061-2071
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2135348048
- Cited by
- 528
- References
- 26
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.